Opinion · 22 Oct 2024
ArticlePublished 2011
Spectrophotometric Determination of Tenofovir Disoproxil Fumarate After Complexation With Ammonium Molybdate And Picric Acid
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
PURPOSE: Tenofovir disoproxil Fumarate (TDF) is a Nucleoside Reverse Transcriptase Inhibitor (NRTI) used in the management of HIV/AIDS. The drug has not been listed in the Official Pharmacopoeias and monographs. Two simple and sensitive methods for the determination of Tenofovir are described. METHODS: The first method involved the acid hydrolysis of the orthophosphate group of tenofovir disoproxil and its subsequent complexation with ammonium molybdate- Stannous Chloride to form a coloured complex with absorption maximum (ëmax) at 495nm. The second method involves complexation of the hydrolyzed tenofovir with picric acid to form a blue coloured complex that absorbed maximally (ëmax) at 465 nm. RESULTS: Both complexations obeyed Beer-Lamberts Law over the wide range of concentrations investigated. Complexation with ammonium molybdate-stannous Chloride and picric acid gave a mean recovery of 99.20% and 96.12% respectively. Their molar absorptivities were also calculated to be 1,234.09 Mol l-1cm-1 and 12,330.92 Mol l-1cm-1 respectively. The Sandell?s sensitivity were similarly determined as 1.94 and 19.40 respectively. Comparison of the two methods by Student?s t-test suggested that they are not significantly different (t ≥ 5 %). CONCLUSION: This results from this investigation show that both methods are suitable for evaluating the quality of the tenofovir disoproxil formulation and can be used for its routine quality control
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Drug Development and Research.
Opinion · 22 Oct 2024
From Monoclonal Antibodies to CAR-T Therapy: Trends and Transformations in Cancer Treatment
Perspective · 21 Oct 2024
Natural Products in Drug Discovery: From Traditional Remedies to Modern Medicines
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Drug Development and Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Johnson O. Onah”
- BylineArticles whose byline prints “Ukpe Ajima”
